Literature DB >> 11201779

Treatment of progressive or recurrent epithelial ingrowth with ethanol following laser in situ keratomileusis.

W W Haw1, E E Manche.   

Abstract

PURPOSE: To evaluate the use of ethanol in the treatment of progressive or recurrent epithelial ingrowth following laser in situ keratomileusis (LASIK).
METHODS: Four eyes of four patients with aggressive epithelial ingrowth following LASIK underwent epithelial ingrowth removal with 50% ethanol. Aggressive epithelial ingrowth was defined as, 1) progressive enlargement on serial examination with an area of ingrowth involving at least 30% of the flap surface area, 2) epithelial ingrowth associated with stromal melting as evidence on clinical or topographic examination, or 3) recurrent epithelial ingrowth in the same area following previous removal.
RESULTS: Epithelial ingrowth was removed successfully in all eyes. No eye lost best spectacle-corrected visual acuity. One eye with multiple risk factors for failure experienced nonprogressive recurrence. No eyes required reoperation for recurrent epithelial ingrowth. No eyes experienced progression of stromal melt. Regularization of corneal topography was observed in an eye with preoperative stromal melting. The only complication was a tendency for the development of diffuse lamellar keratitis. Two eyes (50%) experienced diffuse lamellar keratitis following epithelial ingrowth removal with ethanol, which resolved completely with topical corticosteroids.
CONCLUSION: Ethanol may be a useful adjunct in the treatment of aggressive or recurrent epithelial ingrowth following LASIK. Cautious use with the lowest concentration of ethanol may prove useful in these difficult epithelial ingrowth cases. Randomized and prospective studies are recommended to evaluate our experience.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11201779     DOI: 10.3928/1081-597X-20010101-08

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  3 in total

Review 1.  Epithelial ingrowth following laser in situ keratomileusis (LASIK): prevalence, risk factors, management and visual outcomes.

Authors:  Darren Shu Jeng Ting; Sathish Srinivasan; Jean-Pierre Danjoux
Journal:  BMJ Open Ophthalmol       Date:  2018-03-29

2.  Disruption of ingrown epithelium via Nd:YAG laser or DIEYAG. A retrospective case series of Post-LASIK patients.

Authors:  Ryan J Cosgrove; Matthew J Borr; Michael L Keil
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-23

3.  Post-Laser In Situ Keratomileusis Epithelial Ingrowth: Treatment, Recurrence, and Long-Term Results.

Authors:  Nilufer Yesilirmak; Priyanka Chhadva; Florence Cabot; Anat Galor; Sonia H Yoo
Journal:  Cornea       Date:  2018-12       Impact factor: 3.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.